Why the study?
BMI does not account for substantial inter-individual differences in regional fat and muscle compartments that are relevant for cardiometabolic and cancer prevalence.
Does regional body composition assessed by automated MRI segmentation associate with cardiometabolic and cancer prevalence independently of BMI in adults?
Cross-Sectional (n=45,851)
Yes
Does regional body composition assessed by automated MRI segmentation associate with cardiometabolic and cancer prevalence independently of BMI in adults?
Odds Ratio: 1.19 (95% CI 1.14–1.24)
Automated deep learning-based MRI phenotyping reveals that regional body composition, particularly visceral and gluteofemoral fat, is strongly associated with cardiometabolic and cancer prevalence independent of BMI.
Body mass index (BMI) does not account for substantial inter-individual differences in regional fat and muscle compartments, which are relevant for the prevalence of cardiometabolic and cancer conditions. We applied a validated deep learning pipeline for automated segmentation of whole-body MRI scans in 45,851 adults from the UK Biobank and German National Cohort, enabling harmonized quantification of visceral (VAT), gluteofemoral (GFAT), and abdominal subcutaneous adipose tissue (ASAT), liver fat fraction (LFF), and trunk muscle volume. Associations with clinical conditions were evaluated using compartment measures adjusted for age, sex, height, and BMI. Our analysis demonstrates that regional adiposity and muscle volume show distinct associations with cardiometabolic and cancer prevalence, and that substantial disease heterogeneity exists within BMI strata. The analytic framework and reference data presented here will support future risk stratification efforts and facilitate the integration of automated MRI phenotyping into large-scale population and clinical research.
No takes yet. Share an insight, caveat, or question.
Mertens et al. (2025) conducted a cross-sectional in Cardiometabolic and cancer conditions (n=45,851). Higher visceral adipose tissue (VAT) volume vs. Lower VAT volume (per 1 SD difference) was evaluated on Prevalence of type 2 diabetes per 1 SD higher visceral adipose tissue (VAT) volume (OR 1.19, 95% CI 1.14-1.24).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: